Medpace Holdings, Inc.
MEDP
Classifica tra le azioni
#1303
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Prezzo delle azioni
$622.03
Ultima sincronizzazione: 2026-10-20
Capitalizzazione di mercato
$17.36B
Variazione (1 giorno)
0.38%
Variazione (1 anno)
14.00%
Paese
US
Scambia Medpace Holdings, Inc. (MEDP)
Categoria
Healthcare
Ricavi di Medpace Holdings, Inc. (MEDP)
Ricavi nel Jun 2026 TTM: $2.78B
Secondo gli ultimi rapporti finanziari di Medpace Holdings, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $2.78B. Nel 2024, l'azienda ha registrato ricavi di $2.11B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $1.89B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Medpace Holdings, Inc. da 2013 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $2.78B | 9.96% |
| 2025 | $2.53B | 19.97% |
| 2024 | $2.11B | 11.84% |
| 2023 | $1.89B | 29.17% |
| 2022 | $1.46B | 27.80% |
| 2021 | $1.14B | 23.38% |
| 2020 | $925.93M | 7.54% |
| 2019 | $860.97M | 22.19% |
| 2018 | $704.59M | 61.55% |
| 2017 | $436.15M | 3.46% |
| 2016 | $421.58M | 17.41% |
| 2015 | $359.06M | 23.80% |
| 2014 | $290.04M | 6.28% |
| 2013 | $272.89M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.34B | 1,565.39% |
US
|
|
| $25.11B | 802.39% |
US
|
|
| $2.71B | -2.70% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 164.96% |
US
|
